CTL Biotech Co., Ltd announced that it will issue 2,400 shares at a price of KRW 500,000 per share for gross proceeds of KRW 1,200,000,000 on July 6, 2022. The transaction will include participation from new investor Solco Biomedical Co., Ltd. The company will issue shares through third party allotment. The transaction has been approved by the board of directors of the company.

The transaction is expected to close on July 8, 2022.